Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs

 

Before Recommending the RTS,S Malaria Vaccine for Wider Use, WHO Should Address Three Key Considerations

Last month, the world woke up to promising news on malaria prevention: administering an existing malaria vaccine (RTS,S) in addition to antimalarial drugs before the rainy season reduced child hospitalizations and deaths by approximately 70 percent in Burkina Faso and Mali. These results arrived ahead of a forthcoming decision from the World Health Organization on whether to recommend RTS,S for broader use. This blog argues that WHO should consider value for money and address three key considerations before making their reccomendation.

Getting the Best We Can Buy: Three Solutions to Improve the Use of Value for Money Evidence in Global Development

The need for effective evidence-informed priority-setting in global development is more urgent than ever, with widespread global challenges and reduced funding due to both COVID-19 related public spending and economic slowdowns. This blog explores three key barriers to using value for money evidence in global development and offers three solutions to overcome these challenges.